Post-earnings recap
Reported
Wed, Apr 17, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $0.89, which was below expectations, resulting in a stock decline of 1.68%. The lack of revenue data and guidance may raise concerns among investors about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.89 | N/A | -14.83% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.